Registro:

Referencias:

• Rodriguez, J.B., Falcone, B.N., Szajnman, S.H., Detection and treatment of Trypanosoma cruzi: a patent review (2011–2015) (2016) Expert Opin Ther Pat, 26, pp. 993-1015
• Urbina, J.A., New insights in Chagas disease treatment (2010) Drugs Future, 35, pp. 409-420
• Urbina, J.A., Specific chemotherapy of chagas disease: relevance, current limitations and new approaches (2010) Acta Trop, 115, pp. 55-68
• Bern, C., Chagas disease (2015) N Engl J Med, 373, pp. 456-666
• Brener, Z., Biology of Trypanosoma cruzi (1973) Annu Rev Microbiol, 27, pp. 347-382
• Kirchhoff, L.V., Epidemiology of American trypanosomiasis (Chagas disease) (2011) Adv Parasitol, 75, pp. 1-18
• Urbina, J.A., Docampo, R., Specific chemotherapy of Chagas disease: controversies and advances (2003) Trends Parasitol, 19, pp. 495-501
• Bustamante, J.M., Tarleton, R.L., Potential new clinical therapies for Chagas disease (2014) Expert Rev Clin Pharmacol, 7, pp. 317-325
• Viotti, R., Alarcón De Noya, B., Araujo-Jorge, T., Towards a paradigm shift in the treatment of chronic Chagas disease (2014) Antimicrob Agents Chemother, 58, pp. 635-639
• Ferreira, A.M., Sabino, E.C., De Oliveira, L.C., Benznidazole use among patients with chronic Chagas cardiomyopathy in an endemic region of Brazil (2016) PLoS ONE, 11, p. e0165950
• Macedo-Silva, S.T., de Visbal, G., Urbina, J.A., Souza, W., de Rodrigues, J.C.F., Potent In vitro antiproliferative synergism of combinations of ergosterol biosynthesis inhibitors against Leishmania amazonensis (2015) Antimicrob Agents Chemother, 59, pp. 6402-6418
• Liu, C.-I., Jeng, W., Chang, W.-J., Shih, M.-F., Ko, T.-P., Wang, A.H.-J., Structural insights into the catalytic mechanism of human squalene synthase (2014) Acta Crystallogr D Biol Crystallogr, D70, pp. 231-241
• Tansey, T.R., Shechter, I., Structure and regulation of mammalian squalene synthase (2000) Biochim Biophys Acta, 1529, pp. 49-62
• Thompson, J.F., Danley, D.E., Mazzalupo, S., Milos, P.M., Lira, M.E., Harwood, H.J., Truncation of human squalene synthase yields active, crystallizable protein (1998) Arch Biochem Biophys, 350, pp. 283-290
• Pandit, J., Danley, D.E., Schulte, G.K., Crystal structure of human squalene synthase (2000) Biochemistry, 275, pp. 30610-30617
• Sealey-Cardona, M., Cammerer, S., Jones, S., Kinetic characterization of squalene synthase from Trypanosoma cruzi: selective inhibition by quinuclidine derivatives (2007) Antimicrob Agents Chemother, 51, pp. 2123-2129
• Urbina, J.A., Concepcion, J.L., Rangel, S., Visbal, G., Lira, R., Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana (2002) Mol Biochem Parasitol, 125, pp. 35-45
• Blagg, B.S.J., Jarstfer, M.B., Rogers, D.H., Poulter, C.D., Recombinant squalene synthase. A mechanism for the rearrangement of presqualene diphosphate to squalene (2002) J Am Chem Soc, 124, pp. 8846-8853
• Moraes, I., Evans, G., Sanchez-Weatherby, J., Newstead, S., Stewart, P.D.S., Membrane protein structure determination - the next generation (2014) Biochim Biophys Acta, 1838, pp. 78-87
• Urbina, J.A., Concepcion, J.L., Caldera, A., In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors against Trypanosoma cruzi (2004) Antimicrob Agents Chemother, 48, pp. 2379-2387
• Cinque, G.M., Szajnman, S.H., Zhong, L., Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi (1998) J Med Chem, 41, pp. 1540-1554
• Urbina, J.A., Concepcion, J.L., Montalvetti, A., Rodriguez, J.B., Docampo, R., Mechanism of action of 4-phenoxyphenoxyethyl thiocyanate (WC-9) against Trypanosoma cruzi, the causative agent of Chagas’ disease (2003) Antimicrob Agents Chemother, 47, pp. 2047-2050
• Elhalem, E., Bailey, B.N., Docampo, R., Ujváry, I., Szajnman, S.H., Rodriguez, J.B., Design, synthesis, and biological evaluation of aryloxyethyl thiocyanate derivatives against Trypanosoma cruzi (2002) J Med Chem, 45, pp. 3984-3999
• Liñares, G.G., Gismondi, S., Codesido, N.O., Moreno, S.N.J., Docampo, R., Rodriguez, J.B., Fluorine-containing aryloxyethyl thiocyanate derivatives are potent inhibitors of Trypanosoma cruzi and Toxoplasma gondii proliferation (2007) Bioorg Med Chem Lett, 17, pp. 5068-5071
• Szajnman, S.H., Yan, W., Bailey, B.N., Docampo, R., Elhalem, E., Rodriguez, J.B., Design and synthesis of aryloxyethyl thiocyanate derivatives as potent inhibitors of Trypanosoma cruzi proliferation (2000) J Med Chem, 43, pp. 1826-1840
• Elicio, P.D., Chao, M.N., Galizzi, M., Design, Synthesis and biological evaluation of WC-9 analogs as antiparasitic agents (2013) Eur J Med Chem, 69, pp. 480-489
• Chao, M.N., Matiuzzi, C.E., Storey, M., Aryloxyethyl thiocyanates are potent growth inhibitors of Trypanosoma cruzi and Toxoplasma gondii (2015) ChemMedChem, 10, pp. 1094-1108
• Chao, M.N., Li, C., Storey, M., Activity of fluorine-containing analogues of WC-9 and structurally related analogues against two intracellular parasites: Trypanosoma cruzi and Toxoplasma gondii (2016) ChemMedChem, 11, pp. 2690-2702
• Bazzini, P., Wermuth, C.G., Substituent Groups (2015) The Practice of Medicinal Chemistry, pp. 348-349. , C.G. Wermuth D. Aldous P. Raboisson D. Rognan Academic Press
• Rodriguez, J.B., Marquez, V.E., Nicklaus, M.C., Barchi, J.J., Jr., Synthesis of cyclopropane-fused dideoxycarbocyclic nucleosides structurally related to neplanocin C (1993) Tetrahedron Lett, 34, pp. 6233-6236
• Rodriguez, J.B., Marquez, V.E., Nicklaus, M.C., Mitsuya, H., Barchi, J.J., Jr., Conformationally locked nucleoside analogues. Synthesis of dideoxycarbocyclic nucleoside analogues structurally related to neplanocin C (1994) J Med Chem, 37, pp. 3389-3399
• Nogueira, C.W., Zeni, G., Rocha, J.B.T., Organoselenium and organotellurium compounds: toxicology and pharmacology (2004) Chem Rev, 104, pp. 6255-6285
• Martín-Montes, A., Plano, D., Martín-Escolano, R., Library of seleno-compounds as novel agents against Leishmania species (2017) Antimicrob Agents Chemother, 61, pp. e02546-16
• Baquedano, Y., Nguewa, P., Moreno, E., Espuelas, S., Palop, J.A., Plano, D., Novel heteroaryl selenocyanates and diselenides as potent antileishmanial agents (2016) Antimicrob Agents Chemother, 60, pp. 3802-3812
• Shang, N., Li, Q., Ko, T.P., Squalene synthase as a target for Chagas disease therapeutics (2014) PLoS Pathog, 10, p. e1004114
• Frisch, M.J., Trucks, G.W., Schlegel, H.B., Gaussian 16, Revision A.03 (2016), Gaussian Inc. Wallingford CT; Lin, Y.S., Park, J., De Schutter, J.W., Design and synthesis of active site inhibitors of the Human farnesyl pyrophosphate synthase: Apoptosis and inhibition of ERK phosphorylation in multiple myeloma cells (2012) J Med Chem, 55, pp. 3201-3215
• Maiti, D., Buchwald, S.L., Orthogonal Cu- and Pd-based catalyst systems for the O- and N-arylation of aminophenols (2009) J Am Chem Soc, 131, pp. 17423-17429
• Bruno, N.C., Buchwald, S.L., Synthesis and application of palladium precatalysts that accommodate extremely bulky di-tert-butylphosphino biaryl ligands (2013) Org Lett, 15, pp. 2876-2879
• Bhayana, B., Fors, B.P., Buchwald, S.L., A Versatile catalyst system for Suzuki-Miyaura cross-coupling reactions of C(sp2)-tosylates and mesylates (2009) Org Lett, 11, pp. 3954-3957
• Fors, B.P., Watson, D.A., Biscoe, M.R., Buchwald, S.L., A highly active catalyst for Pd-catalyzed amination reactions (2008) J Am Chem Soc, 130, pp. 13552-13554
• Ruiz-Castillo, P., Buchwald, S.L., Applications of palladium-catalyzed C-N cross-coupling reactions (2016) Chem Rev, 116, pp. 12564-12649
• Rodriguez, J.B., Gros, E.G., Stoka, A.M., Synthesis and biological activity of juvenile hormone analogues (JHA) for Trypanosoma cruzi (1991) Bioorg Med Chem Lett, 1, pp. 679-682
• Schvartzapel, A.J., Zhong, L., Docampo, R., Rodriguez, J.B., Gros, E.G., Design, synthesis, and biological evaluation of new growth inhibitors of Trypanosoma cruzi (epimastigotes) (1997) J Med Chem, 40, pp. 2314-2322
• Rodriguez, J.B., WC-9 a lead drug with great prospects for American trypanosomiasis and toxoplasmosis (2016) Mini-Reviews Med. Chem., 16, pp. 1195-1200
• Liñares, G.E.G., Ravaschino, E.L., Rodriguez, J.B., Progresses in the field of drug design to combat tropical protozoan parasitic diseases (2006) Curr Med Chem, 13, pp. 335-360
• Kwong, F.Y., Buchwald, S.L., A general, efficient, and inexpensive catalyst system for the coupling of aryl iodides and thiols (2002) Org Lett, 4, pp. 3517-3520
• Ho, D.K., McKenzie, A.T., Byrn, S.R., Cassady, J.M., O5-Methyl-(±)-(2'R,3'S)-psorospermin (1987) J Org Chem, 52, pp. 342-347
• Schmidt, B., Riemer, M., Schilde, U., Tandem Claisen rearrangement / 6-endo cyclization approach to allylated and prenylated chromones (2015) Eur J Org Chem, 2015, pp. 7602-7611
• Bohlmann, F., Franke, H., Synthese von racemischem Lomatin, Columbianetin, Angenoma- Lin und Samidin (1971) Chem Ber, 104, pp. 3229-3233
• Murray, R.D.H., Sutcliffe, M., McCabe, P.H., Claisen rearrangements-IV1 oxidative cyclisation of two coumarin O-isopropyl phenols (1971) Tetrahedron, 27, pp. 4901-4906
• Ramadas, S., Krupadanam, G.L.D., Ramadas, S., Krupadanam, G.L.D., Enantioselective acylation of 2-hydroxymethyl-2,3-dihydrobenzofurans catalysed by lipase from Pseudomonas cepacia (Amano PS) and total stereoselective synthesis of (-)-(R)-MEM-protected arthrographol (2000) Tetrahedron Asymmetry, 11, pp. 3375-3393
• Lei, X., Jiang, C.-H., Wen, X., Xu, Q.-L., Sun, H., Formal [4+1] cycloaddition of O-quinone methides: facile synthesis of dihydrobenzofurans (2015) RSC Adv, 5, pp. 14953-14957
• Krafft, G.A., Meinke, P.T., Selenoaldehydes: preparation and dienophilic reactivity (1986) J Am Chem Soc, 108, pp. 1314-1315
• Kariya, N., Allyl cyanate-to-isocyanate rearrangement: preparation of tert-butyl 3,7-dimethylocta-1,6-dien-3-yl carbamate (2013) Org Synth, 90, pp. 271-286
• Baldwin, J.E., Adlington, R.M., Russell, A.T., Smith, M.L., Synthesis of a biologically active analogue of antibiotic A-32390A (1994) J Chem Soc, Chem Commun, 1994, pp. 85-86
• Coppens, I., Sinai, A.P., Joiner, K.A., Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition (2000) J Cell Biol, 149, pp. 167-180
• Pradines, B., Torrentino-Madamet, M., Fontaine, A., Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum (2007) Antimicrob Agents Chemother, 51, pp. 2654-2655
• Bessoff, K., Sateriale, A., Lee, K.K., Huston, C.D., Drug repurposing screen reveals FDA-approved inhibitors of Human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth (2013) Antimicrob Agents Chemother, 57, pp. 1804-1814
• Cortez, E., Stumbo, A.C., Olieveira, M., Barbosa, H.S., Carvalho, L., Statins inhibit Toxoplasma gondii multiplication in macrophages in vitro (2009) Int J Antimicrob Agents, 33, pp. 184-185
• Nair, S.C., Brooks, C.F., Goodman, C.D., Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii (2011) J Exp Med, 208, pp. 1547-1559
• Moreno, S.N.J., Li, Z., Targeting the isoprenoid pathway of Toxoplasma gondii (2008) Expert Opin Ther Targets, 12, pp. 253-264
• Bruno, I.J., Cole, J.C., Kessler, M., Retrieval of crystallographically-derived molecular geometry information (2004) J Chem Inf Comput Sci, 44, pp. 2133-2144
• Spackman, M.A., Jayatilaka, D., Hirshfeld surface analysis (2009) CrystEngComm, 11, pp. 19-32
• Becke, A.D., Becke, A.D., Density functional thermochemistry III. The role of exact exchange (1993) J Chem Phys, 98, pp. 5648-5652
• Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings (2001) Adv Drug Deliv Rev, 46, pp. 3-26
• Moreno-Viguri, E., Jiménez-Montes, C., Martín-Escolano, R., In vitro and in vivo anti-Trypanosoma cruzi activity of new arylamine Mannich base-type derivatives (2016) J Med Chem, 59, pp. 10929-10945
• Canavaci, A.M.C., Bustamante, J.M., Padilla, A.M., N vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds (2010) PLoS Negl Trop Dis, 4, p. e740
• Recher, M., Barboza, A.P., Li, Z.-H., Design, synthesis and biological evaluation of sulfur-containing 1,1-bisphosphonic acids as antiparasitic agents (2013) Eur J Med Chem, 60, pp. 431-440
• Gubbels, M., Li, C., Striepen, B., High-throughput growth assay for Toxoplasma gondii (2003) Antimicrob Agents Chemother, 47, pp. 309-316
• Agrawal, S., van Dooren, G.G., Beatty, W.L., Striepen, B., Genetic evidence that an endosymbiont-derived endoplasmic reticulum-associated protein degradation (ERAD) system functions in import of apicoplast proteins (2009) J Biol Chem, 284, pp. 33683-33691
• CrysAlis, P.R.O., Agilent (2013). Yarnton, Oxfordshire, England. Version: 1.171.36.28 2013; Dolomanov, O.V., Bourhis, L.J., Gildea, R.J., Howard, J.A.K., Puschmann, H., OLEX2: a complete structure solution, refinement and analysis program (2009) J Appl Crystallogr, 42, pp. 339-341
• Sheldrick, G.M., Research papers experimental phasing with SHELXC/D/E: combining chain tracing with density modification (2010) Acta Crystallogr, D66, pp. 479-485
• Sheldrick, G.M., Crystal structure refinement with SHELXL (2015) Acta Crystallogr C, 71, pp. 3-8
• Groom, C.R., Bruno, I.J., Lightfoot, M.P., Ward, S.C., The Cambridge structural database (2016) Acta Crystallogr, B72, pp. 171-179

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------